PR Newswire · Nov 2025
CAHF named Darmiyan its preferred provider, giving more than 1,300 member facilities access to BrainSee for early brain-health assessment and dementia prevention.
Company research
Public company, workplace, funding, and market signals
Overview
Darmiyan is a San Francisco-based neurotechnology and public-health company that uses AI plus brain MRI analysis to screen and monitor brain health, with BrainSee as its flagship FDA-approved prognostic test for estimating progression from amnestic mild cognitive impairment to Alzheimer’s dementia.
Primary product
BrainSee
Founded
2016
Headquarters
San Francisco, California, United States
Team size
11-50
Work style
Onsite
Industry
Public Health
Sub-industry
Neurotechnology / brain health diagnostics
Offices
San Francisco, California, United States
Open Positions
0 jobs at Darmiyan
No open positions
Check back later for new openings